Related Experiment Video
Updated: May 24, 2025

05:07
Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
Published on: June 23, 2019
6.6K
Development of Novel Sulfonamide-Based Pyrazole-Clubbed Pyrazoline Derivatives: Synthesis, Biological Evaluation, and
Mayursinh Zala1, Jwalant J Vora1, Vijay M Khedkar2
1Department of Chemistry, Faculty of Science, Gujarat University, Ahmedabad 380009, India.
ACS Omega
|March 3, 2025
Summary
Novel sulfonamide-based pyrazole derivatives were synthesized to combat multidrug-resistant tuberculosis (MDR-TB). Compound 9g demonstrated potent antimycobacterial activity, showing promise for new tuberculosis treatments.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Antimicrobial Agents
Background:
- Multidrug-resistant tuberculosis (MDR-TB) poses a significant global health threat.
- Development of novel therapeutic agents is crucial for effective tuberculosis treatment.
Purpose of the Study:
- To synthesize and characterize novel sulfonamide-based pyrazole-clubbed pyrazoline derivatives.
- To evaluate the in vitro antimycobacterial activity of synthesized compounds against Mycobacterium tuberculosis H37Rv.
- To investigate the binding interactions of active compounds with the mycobacterial InhA enzyme through molecular docking.
Main Methods:
- Synthesis of target compounds (9a-p) via reaction of chalcone derivatives with 4-hydrazinylbenzenesulfonamide.
- Spectroscopic characterization using ESI-MS, FT-IR, NMR, and UV-Vis spectroscopy.
- Antitubercular activity screening and determination of Minimum Inhibitory Concentration (MIC).
- Molecular docking studies against the InhA enzyme active site.
- In silico ADMET predictions for drug-likeness.
Main Results:
- Successful synthesis of novel sulfonamide-based pyrazole-clubbed pyrazoline derivatives (9a-p).
- Compounds 9g, 9h, 9i, 9j, 9m, and 9n exhibited potent activity against M. tuberculosis H37Rv.
- Compound 9g showed excellent activity with an MIC of 10.2 μg/mL, 99% inhibition, and a docking score of -9.714.
- Molecular docking revealed strong binding affinities for active compounds with the InhA enzyme.
- In silico ADMET predictions suggested favorable drug-like properties for the synthesized molecules.
Conclusions:
- The synthesized sulfonamide-based pyrazole derivatives represent a promising class of compounds for developing new anti-tuberculosis agents.
- Compound 9g is identified as a lead candidate with significant antimycobacterial potential.
- Further investigation into the mechanism of action and in vivo efficacy of these compounds is warranted.
More Related Videos
Related Concept Videos
Structure-Activity Relationships and Drug Design
480
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
480
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
2.9K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
2.9K
Drug Discovery: Overview
7.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.3K

